• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Still more recalls for Johnson & Johnson

Still more recalls for Johnson & Johnson

March 2, 2011 By MassDevice staff

JNJ

Johnson & Johnson (NYSE:JNJ) recalled 104 batches of surgical sutures late last year, after discovering a packaging problem that can render them unsterilized.

It’s the latest in a string of damaging recalls that cost the new Brunswick, N.J.-based medical products conglomerate an estimated $900 million last year.

The company’s Ethicon Inc. division sent out a warning in late December, 2010, in the United Kingdom that it was pulling 104 batches of its Ethilon, Ethibond, Mersilene and Mersilk sutures. Information on the recall hit the Internet today via the U.K.’s Medicines and Healthcare products Regulatory Agency.

"The unit pack in the affected products may not have a complete seal and so the contents may not be sterile," according to the MHRA website.

"This action is being taken as a result of a potential defect in the packaging of selected batches of these products produced during the September 2010 to December 2010 timeframe," according to the Dec. 29, 2010, warning letter from Ethicon (PDF). "This packaging defect could compromise the integrity of the primary seal on product packaging … and we therefore cannot assure sterility of these products."

It’s the latest in a veritable plethora of recalls for J&J and its family of subsidiaries. Last month Ethicon Inc. issued a recall of 700,000 units of a liquid wound sealant and a hernia-treatment device, a day after pulling 70,000 syringes pre-filled with Invega Sustenna, an anti-psychotic drug, due to possible cracks.

J&J also suffered a welter of recalls for its over-the-counter medicine operation and its DePuy ASR hip implant, giving its bottom line a bruising during its most recent fiscal quarter.

Here’s a rundown of Johnson & Johnson recalls going back to 2009, compiled by the Wall Street Journal‘s Health Blog:

  • March 2011: Ethicon pulls 104 batches of surgical sutures
  • February 2011: J&J recalls more than 667,000 Sudafed packages after a discovering a double-negative typo on the label ("do not not divide, crush, chew, or dissolve the tablet")
  • February 2011: J&J pulls at least 395 injection pens preloaded with rheumatoid-arthritis drug Simponi because they may not deliver a full dose of the drug
  • February 2011: Ethicon pulls 700,000 vials of a liquid wound sealant and a hernia-treatment product
  • February 2011: J&J recalls 70,000 syringes preloaded with its Invega injectable anti-psychotic drug over cracks found in the syringes
  • January 2011: J&J pulls 43 million bottles of Tylenol, Benadryl, Sinutab and Sudafed made at its Ft. Washington, Pa., plant while equipment there may not have been properly cleaned and yanks almost 4 million units of Rolaids due to a labeling problem
  • December 2010: The company recalls all lots of Rolaids Extra Strength Softchews, Rolaids Extra Strength Plus Gas Softchews and Rolaids Multi-Symptom Plus Anti-Gas Softchews following consumer reports of foreign-particle contamination
  • December 2010: J&J recalls a dozen different Mylanta liquid products and one AlternaGEL product because they were mislabeled to omit the presence of small amount of alcohol and widened a recall of daily-use contact lenses in Japan and elsewhere due to traces of an acid that can cause stinging
  • November 2010: The company recalls three Tylenol Cold Multi-Symptom products, also due to an alcohol labeling issue
  • November 2010: The company recalls children’s Benadryl and Motrin products
  • October 2010: A recall of 127,000 bottles of Tylenol 8-Hour caplets due to a musty odor.
  • August 2010: J&J’s DePuy Orthopedics unit pulls two hip implants off the market because of an unusually high rate of replacement surgeries
  • August 2010: A recall — recently widened — of about 100,000 boxes of 1-Day Acuvue TruEye contact lenses
  • July 2010: Some OTC medicines are pulled, including varieties of Benadryl, Tylenol and Motrin, in a follow-up to a recall of musty-smelling products made at a plant in Puerto Rico
  • June 2010: The company widens the recall of drugs made at the Puerto Rican plant
  • May 2010: The largest batch of children’s medicines are pulled
  • December 2009: Recalls of Tylenol Arthritis Pain Caplets due to that musty odor issue
  • July 2009: J&J officially recalls batches of Motrin, but has come under fire for an earlier so-called "phantom recall" of the product

Filed Under: News Well, Recalls Tagged With: Johnson and Johnson

In case you missed it

  • Ambu replaces CEO with new leadership
  • Moderna’s first bivalent COVID-19 vaccine booster candidate shows promise
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
  • FDA clears Accelus’ Toro-L interbody fusion system
  • Teleflex’s UroLift cleared in China to treat BPH
  • Globus Medical announces first surgeries with Excelsius3D
  • Abbott reports positive data on heart valve therapies
  • OncoRes Medical raises another $12.5M
  • NeuroMetrix’s Quell neuromodulation device wins FDA de novo nod to treat fibromyalgia
  • Inogen appoints Agnes Lee as senior VP of investor relations, strategic planning
  • Google Health hires FDA’s chief digital health officer
  • ApiJect picks up $111M investment from Royalty Pharma, Jefferies
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
  • Teleflex wins Health Canada nod for Manta vascular closure device
  • Study shows strong performance, improved outcomes with Medtronic Evolut TAVR
  • New FDA clearance expands indications for Xact Robotics’ ablation system
  • Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy

RSS From Medical Design & Outsourcing

  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]
  • How Minnetronix Medical helped Lazurite with its wireless surgical camera
    Minnetronix Medical (St. Paul, Minnesota) has played an important development and manufacturing partner role with Lazurite’s wireless surgical camera system. It’s been nearly two months since Lazurite (formerly Indago) announced FDA 510(k) clearance of its ArthroFree system. ArthroFree combines proprietary low-heat, high-intensity Meridiem light engine technology with advanced camera, battery and wireless transmission technologies and… […]
  • Instron releases TrendTracker data analysis workflow platform
    Instron announced that it released the TrendTracker module in Bluehill Central for accelerating data analysis workflows. Norwood, Massachusetts-based Instron designed TrendTracker with an intuitive interface to improve the data analysis workflow of single or multi-location materials testing laboratories. According to a news release, the platform features quick searching and the ability to display and analyze… […]
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
    Henry Schein (Nasdaq:HSIC) today named Dirk Benson as VP and chief commercial officer of the medical device manufacturer and distributor’s North America Distribution Group (NADG). Melville, New York-based Henry Schein is the world’s largest provider of health care supplies and services for office-based dental and medical practitioners, and NADG is the company’s largest business group. The… […]
  • The road to a robot: Medtronic’s development process for its Hugo RAS system
    Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they eat a lot, making… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS